ESC 365 - SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials

ESC Professional Premium Access

SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials

Session: Pharmacology and Pharmacotherapy

Topic: Treatment

Speaker: Doctor P. Sharma (Kanpur, IN)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

About the speaker

Doctor Prachi Sharma

LPS Institute of Cardiology, Kanpur (India)

0 follower

2 more presentations in this session

Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2

Speaker: Mr H. Hermawan (Surabaya, ID)

Access the full session

Pharmacology and Pharmacotherapy

Speakers: Doctor P. Sharma, Doctor R. Cordovez, Mr H. Hermawan

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by